CEB-01 by Cebiotex for Soft Tissue Sarcoma: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Soft Tissue Sarcoma.

Opinion | Doctor’s Orders: A Social Prescription for Health

Hotz is a solutions-focused journalist. Last month, a viral video explaining an MIT neurosurgeon’s decision to quit the field unearthed the many frustrations that millions

July 30, 2024

Breaking: J&J looks at potential bid for Intra-Cellular — report

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 13, 2025

Study advances understanding of complex neurological disorder

To effectively treat a disease or disorder, doctors must first know the root cause. Such is the case for developmental and epileptic encephalopathies (DEEs), whose

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.